Inspira Technologies says ART100 in use at Tier-1 U.S. hospitals
#Product Stage #Customers
Inspira’s ART100 in Use at Tier-1 U.S. Hospitals, Generating Strong Clinical Interest and Accelerating Sales Discussions
#Product Stage #Customers #FDA approved/pending approval
Inspira Technologies scales up ART100 production capabilities
#Product Stage #Customers #Management Changes
Inspira Scales Up ART100 Production Capabilities Amid Advanced Negotiation with European Government Authority
#Product Stage #Customers #FDA approved/pending approval
CORRECTION - Inspira Scales Up ART100 Production Capabilities Amid Advanced Negotiation with European Government Authority
#Product Stage #Customers #FDA approved/pending approval
Inspira Technologies Initiates Global Commercial Rollout of FDA-Cleared ART100 System
#Product Stage #Customers #FDA approved/pending approval
Inspira Technologies Aligns Executive Team Amid Corporate Structuring Initiatives
#Management Changes
INSPIRA ART100 System Approved by Israel's Largest Healthcare Provider for Use in Organ Transplant Patients
#Product Stage #Customers
Inspira Achieves above 99% Gas Exchange Efficiency in VORTX™ Technology In-Vivo Animal Testing
#Product Stage #FDA approved/pending approval
Inspira Technologies Generates First Revenues from Deployment of INSPIRA ART100 Systems
#Product Stage #Customers #Partners
Inspira Technologies Announces Successful Treatment of First Patient with INSPIRA ART100 at Westchester Medical Center
#Product Stage #Customers #Partners
Inspira Technologies Announces Successful Installation of INSPIRA ART100 Systems in Premier U.S. Hospital
#Product Stage #Customers
Market Alert: Inspira Technologies' Respiratory Tech Could Transform $19B Ventilator Market Amid Major Wave of Multi Billion Dollar Medtech Acquisitions
#Product Stage #Customers
Inspira Technologies' Innovative Life-Support System to be Showcased at AmSECT 63rd International Conference 2025 in San Diego
#Product Stage #Partners
PESG Report: Inspira Technologies' AI-Powered Respiratory System Could Revolutionize Care for 20 Million Annual ICU Patients in Combined $25+ Billion Market
#Product Stage #FDA approved/pending approval
/PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. ("Inspira," "Inspira Technologies" or the "Company") (Nasdaq: IINN), a pioneering force in the evolution...
undefined
Inspira Technologies Releases CEO Update: Major Milestones Signal Next-Level Respiratory Care
#Product Stage #FDA approved/pending approval
Inspira Technologies Receives Nasdaq Notification Regarding Minimum Bid Requirement
undefined
/PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic...
undefined
/PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic...
undefined
Inspira Technologies Reports Full Year 2024 Financial Results and Provides Business Updates
#Product Stage #Partners #Management Changes #FDA approved/pending approval
PESG Report: Inspira Technologies Breaks new Ground with Positive Clinical Data for AI-Powered Blood Sensor Exceeding Expectations
#Product Stage #Customers #Partners #FDA approved/pending approval
Inspira Technologies Announces Positive Results from Clinical Study of HYLA Blood Sensor, Achieving 96% Accuracy
#Product Stage
EXCLUSIVE: Inspira and Ennocure's Bio-Electronic Tech Uses Electric Stimulation to Help Prevent IV-Related Infections
#Product Stage #Partners
Inspira Achieves Positive Results of Above 95% For Preventing Bloodstream Infections
#Product Stage #Partners #FDA approved/pending approval
/PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) ("Inspira" or the "Company"), a pioneer in breakthrough life-support technology, today...
#Product Stage #Partners
Inspira Technologies Oxy B.H.N. Ltd. (IINN) Enhances HYLA™ Sensor with AI Oxygenation Indicator
undefined
PESG Report: Inspira Technologies Strengthens its AI-Powered Blood Sensor with new Capabilities, Intends to Share Clinical Findings Soon
#Product Stage #FDA approved/pending approval
/PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) ("Inspira" or the "Company"), a pioneer in breakthrough life-support technology, today...
#Product Stage #FDA approved/pending approval
EXCLUSIVE: Isreal-Based Inspira Technologies Integrates New Oxygenation Indicator Into HYLA Blood Sensor To Enhance Critical Care Monitoring
#Product Stage
Inspira Technologies Integrates New Oxygenation Indicator into AI-Powered HYLA Blood Sensor
#Product Stage #FDA approved/pending approval
Inspira™ Introduces Advanced Features for INSPIRA™ ART100, Further Amplifying User and System Support
#Product Stage
Inspira™ Technologies Prepares its First Life-Support Systems for Deployment at a Leading U.S. Hospital
#Product Stage #Customers #Partners
/PRNewswire/ -- Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) (NASDAQ: IINNW), ("Inspira Technologies," "Inspira" or the "Company"), a groundbreaking...
#Product Stage #FDA approved/pending approval
Inspira™ Announces the Appointment of Tal Parnes as the New Chairman of the Board, Bringing Vast Experience in the Medical Technology and Pharmaceutical Sectors
#Management Changes
/PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) ("Inspira" or the "Company"), a leader in life-support technology...
#Management Changes
Inspira™ Technologies Collaborates With Zriha Medical To Launch Cutting-Edge Production Line
#Partners
Inspira™ Technologies Unveils Modular Configuration for Revolutionary VORTX™ Blood Oxygenation Delivery Technology
undefined
/PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) ("Inspira" or the "Company"), a leader in life-support technology innovation, is...
#Product Stage #FDA approved/pending approval
EXCLUSIVE: Inspira Technologies Unveils Modular Configuration For VORTX Blood Oxygenation Delivery Technology
#Expand
Inspira™ Preparing Production in Response to Spread of Respiratory Virus in China
#Product Stage
/PRNewswire/ -- Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) (NASDAQ: IINNW), ("Inspira Technologies," "Inspira" or the "Company"), a groundbreaking...
#Product Stage #FDA approved/pending approval #Partners
Inspira™ Technologies Flagship Technology to be Showcased at Arab Health Expo 2025 in Dubai
#FDA approved #Partners
Inspira™ Announces Pricing of $3.2M Private Placement by New and Existing Investors of the Company
#Investment
Inspira™ Technologies Delivers Systems to Leading Distributor for U.S. Deployment
#Customers #Partners
/PRNewswire/ -- Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN, IINNW), ("Inspira Technologies," "Inspira" or the "Company"), a groundbreaking respiratory...
#Customers #Partners
Inspira™ Expands HYLA™ Blood Sensor Technology into Personalized Blood Lab Testing for Rapid Detection of Serious Medical Conditions
#Expand
/PRNewswire/ -- Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN, IINNW), ("Inspira Technologies" or the "Company"), a groundbreaking life support technology...
undefined
Inspira™ Collaborates with New York's Westchester Medical Center to Evaluate the INSPIRA™ ART100 Functionality and Performance in Clinical Scenarios
#Partners
/PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN), (Nasdaq: IINNW) ("Inspira Technologies", "Inspira" or the "Company"), a groundbreaking...
#Partners
Join Inspira™ Technologies' Live Investor Webinar and Q&A Session on November 11
undefined
/PRNewswire/ -- Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN), ("Inspira Technologies" or the "Company"), an innovative medical technology company in the...
undefined
/PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) ("Inspira Technologies", "Inspira" or the "Company"), a groundbreaking life support...
#Partners
Inspira™ Announces Establishment of Distribution Facility to Support U.S. Deployment of INSPIRA™ ART100
#Partners #Customers
Inspira™ Announces Development of New Disposable Kit with Built-In Performance Monitoring Mechanism
#Customers
Inspira Stock to Gain From its Appearance at Annual ELSO Conference
#Customers #Partners
Inspira™ Launches INSPIRA™ ART100 at the World's Largest Extracorporeal Life Support Conference
#Customers #Partners
IINN Stock Gains on Second US Patent Approval for VORTX System
#Investment
Inspira gains new US patent approval for blood oxygenation system
#Investment
Inspira™ Secures a Second U.S. Patent Approval for Orbiting Blood Oxygenation Delivery System
undefined
Favorable Clinical Results for HYLA Sensor Might Boost Inspira Stock
#Expand
/PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) ("Inspira" or the "Company"), a leader in life-support technology...
#Expand
Inspira™ to Publish HYLA™ Clinical Results in Fourth Quarter 2024
#Customers #Expand
INSPIRA (IINN) CART Gets FDA Listing, to Enhance Healthcare
#Customers #Partners #Expand
Inspira™ Technologies Announces FDA Listing and Market Readiness of New Product
#Customers #Partners #Expand
Inspira™ Approached by Large Medical Company to Evaluate Operation of their Key Product with INSPIRA™ ART100 - Results Exceed 100% at Maximum Flow
undefined
Inspira™ Technologies Introduces the INSPIRA Cardi-ART, Aiming to Provide Oxygen to the Brain During Cardiac Arrest
#Investment, Expand
Inspira Technologies gains key Israeli approval for INSPIRA ART100 system
#Customers #Partners
Inspira™ Receives Israeli Regulatory Approval for the INSPIRA™ ART100 System
#Customers #Expand
Inspira (IINN) Unveils Business Targets for 2024-25
#Customers #Partners #Expand
Inspira™ Announces Business Plan Targets
#Customers #Partners #Expand
Inspira™ Introduces Advanced Life Support Solutions to Key International Leaders at the Annual iECOs Conference in Israel
#Customers, Expand
Inspira™ Receives First Ever Purchase Order for INSPIRA™ ART100 Systems in the U.S.
#Customers #Partners #Expand
Inspira™ to Exhibit the FDA Cleared INSPIRA™ ART100 System at a World-Renowned Event in the Sector
#Customers, Partners
Inspira™ Technologies Announces Business Targets Presentation Following FDA Clearance and Significant Developments
#Management Changes #Partners
Inspira Technologies' (IINN) ART100 Gets FDA 510(k) Grant
#Investment #Partners
INSPIRA™ ART100 Receives FDA 510(k) Clearance
#Investment #Partners
Inspira™ Announces Start of Production of the INSPIRA™ ART100
#Customers #Partners
Inspira™ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA™ ART100
#Customers
Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant Procedures
#Partners
Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream Infections
#Partners, Research and Development
Inspira™ Announces Program to Pioneer the Applicable Use of the INSPIRA™ ART100 Device for an Artificial Womb
#Customers #Expand
Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund Manager
#Investment
Companies Like Inspira Technologies Oxy B.H.N (NASDAQ:IINN) Could Be Quite Risky
#Investment
Inspira™ Technologies Reports Full Year 2023 Financial Results
#Customers #Partners #Management Changes
Inspira Technologies (IINN) Strives to Get AMAR Nod for ART100
#Customers #Expand
Inspira™ Announces AMAR Regulatory Submission of the INSPIRA™ ART100, to Enter the Southeast Asia and South American Markets
#Customers #Expand
Inspira Technologies (IINN) Releases Favorable Data on VORTX
#Customers #Investment
Inspira™ Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS Indicator
#Investment
Inspira™ Announces Plans to Report the Primary Results for a Core Blood Oxygenation Technology Within Days
#Investment #Expand
Inspira™ To Host Conference Call to Discuss Investor Presentation and Announce Next Major Milestone
undefined
Inspira™ Announces Breakthrough Update: Nears First FDA 510(k) Approval, 3 U.S. Patents Approved, $546 million in Summary Distribution Agreements
#Customers #Partners #Investment
Inspira™ introduces high-end platform for bio-mimicking blood parameters for development and testing of core technologies
#Investment, Expand
15 Hot Penny Stocks On the Move
#Investment
Inspira™ Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System
#Customers #Investment
Inspira™ Technologies Collaborates with a Leading Israeli Medical Center for Clinical Evaluation of INSPIRA™ ART Device
#Partners
Inspira™ Technologies Signs Strategic Agreement to Enter Gulf States with Glo-Med for Deployment of 531 INSPIRA™ ART Devices
#Partners #Expand
Inspira™ Announces Plans to Launch and Target Single-Use Disposable Blood Oxygenation Kit for a New Disposable Perfusion Market Opportunity
#Customers #Expand
Inspira™ Technologies Signs Letter of Intent with Northwestern Memorial Hospital in Chicago for Clinical Use of INSPIRA™ ART100 Device
#Partners #Expand
Inspira™ Technologies Closes on $3.88 Million Registered Direct Offering
#Investment
Inspira Announces $3.88 Million Registered Direct Offering
#Investment
Inspira™ Announces 95% Accuracy Results for HYLA™ Blood Sensor, Planning FDA Submission for Clearance in 2024
#Customers #Partners
Inspira Technologies to Participate in J.P. Morgan Healthcare Conference
#Management Changes #Expand
In Preparation for FDA Clearance and Device Deployment, Inspira has Appointed Dr. Dan Gorfil, to Medical Advisory Board
#Management Changes
Inspira (IINN) Expands in Life Support Space With New Deal
#Partners
Inspira Collaborates with Ennocure for development of a Proprietary Bio-Electronic Treatment to Prevent Associated Bloodstream Infections in ICU Patients
#Partners #Expand
Inspira™ Technologies Reports Third Quarter 2023 Financial Results
#Investment #Expand
Inspira™ Announces Israeli Innovation Authority Grant for New VORTX™ Disposable Blood Oxygenation Technology
#Investment
Inspira™ Granted U.S. Patent for INSPIRA™ ART500 Medical Device
#Investment
Inspira™ Terminates ATM Program and Provides an Update
#Customers #Partners
Inspira™ Enters into a Distribution Agreement in Central America with CIO MED GROUP
#Partners #Expand
Inspira™ Technologies Unveils the INSPIRA™ ART Line of Medical Devices at the World's Largest Extracorporeal Life Support Conference
#Customers #Partners
Inspira™ Announces 510(k) FDA Submission of INSPIRA™ ART100 Towards Commercialization
#Investment #Expand
Inspira (IINN) Advances Foothold in Europe With Extended Deal
#Partners #Customers
Inspira™ Signs Agreement Expansion with Innovimed for Clinical Trials of INSPIRA™ ART Respiratory Medical Devices
#Partners
Inspira™ Technologies Reports Second Quarter 2023 Financial Results
undefined
INSPIRA™ ART100 Completes Usability Study in Boston Massachusetts, U.S.
#Customers #Expand
Inspira™ Technologies Receives Certification of Medical Devices Quality Management Systems, Another Step Towards EU Regulatory Approval
#Customers
Inspira™ Technologies Enters into Collaboration Agreement with U.S.-Based Perfusion Solution Inc.
#Partners
Inspira™ Technologies Unveils Investor Deck Showcasing Revolutionary Advancement in Acute Respiratory Care
#Investment #Partners
Inspira Technologies Appoints Dr. Nir as Chief Medical Officer
#Management Changes
Inspira™ Technologies Reports First Quarter 2023 Financial Results
#Investment #Expand
Inspira™ Technologies will Reveal the New ALICE™ Device at the World's Largest Extracorporeal Life Support Conference
#Partners #Investment
Inspira™ Technologies is Developing the VORTX™ Blood Oxygenator, a Unique Technology for Saturating Blood With Oxygen and Removing Carbon Dioxide
#Customers #Investment
Inspira Technologies and Genius Group Interviews to Air on Bloomberg TV on the RedChip Money Report(R)
undefined
Inspira(TM) Technologies to Present at the Planet MicroCap Showcase 2023 on Wednesday, April 26, 2023 in Las Vegas
#Partners
Keynotes, Educational Panels and 77 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 25-27, 2023 at the Horseshoe Hotel & Casino in Las Vegas, NV
undefined
Inspira™ Technologies Reports Fourth Quarter 2022 and Full Year Financial Results
undefined
Inspira™ Technologies Announces First in Human of HYLA™ Blood Sensor in Clinical Study
#Customers
Inspira™ Technologies Receives Approval from Sheba Medical Center to Conduct Clinical Study of the HYLA™ Blood Sensor
#Customers
Inspira™ Technologies Granted Patent by U.S. Patent Office for the INSPIRA™ ART System's Convertible Dual Lumen Cannula Device and Method of Use
undefined
Diamond Equity Research Initiates Coverage on Inspira Technologies Ltd. (NASDAQ: IINN)
undefined
Inspira™ Technologies Signs Strategic OEM Agreement with Terumo Cardiovascular
undefined
Inspira(TM) Technologies Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
undefined
Inspira™ Technologies Interview to Air on Bloomberg U.S. on the RedChip Money Report®
#Partners
Inspira™ Technologies Begins Manufacturing of the ALICE™ CPB Device, ahead of planned 2023 FDA submission
undefined
Inspira™ Technologies Signs Agreement to Conduct Clinical Study of HYLA™ Blood Sensor
#Partners
Inspira™ Technologies Reports Third Quarter 2022 Financial Results
#Investment #Partners
Inspira™ Technologies Signs a Strategic Agreement in Europe to potentially provide $26.1 for Deployment of 1,364 HYLA™ Blood Sensors
#Partners
Inspira™ Technologies Granted Patent by the Israeli Patent Office for Key Safety Component for the INSPIRA™ ART System
undefined
Inspira™ Technologies Develops a Non-Invasive Blood Sensor Designed to Alert Real-Time Change in Patients - Potentially Targets $2.5 Billion ABG Market
#Customers
Inspira Technologies Has Listed an FDA Class I 510(k) Exempt component of the ART system
#Customers
Inspira™ Technologies Reveals Next Generation Liby™ System, an Extracorporeal Membrane Oxygenation System, Targeting a $531 Million Global ECMO Market
#Investment #Customers
Inspira Technologies Announces Deployment Agreement in the Israeli Market to Target $15M
#Partners
Inspira Technologies Signs a Strategic Agreement in the U.S. to Target $212 Million for Inspira Over a 7-Year Period, Subject to Regulatory Approvals
#Partners
Inspira Technologies' "Artificial Lung" to Acquire a Digital Edge: The Company Contracted GlobalLogic, a Hitachi Group Company, for advanced digital product engineering services
#Partners
Inspira Technologies Reached Important Milestone as It Completed a Pump Bench Study
#Investment #Expand
Inspira Technologies and Ben-Gurion University Have Developed a Platform Designed to Prevent Blood Clotting in Inspira's ART System
#Partners #Investment
Inspira Technologies OXY B.H.N. Ltd Announces Closing of Initial Public Offering
#Public Trading
Inspira Technologies OXY B.H.N. Ltd Announces Pricing of Initial Public Offering
#Public Trading
Q&A: An intelligent oxygenation system that could eliminate need for ventilators
#Customers
הקורונה מטיסה את שאיפות ההנפקה של אינספירה
#Investment #Public Trading #Partners
Inspira Technologies Files U.S. Patent Application for its Innovative Respiratory Support Technology;Engages Leading U.S. Investment Bank for NASDAQ Listing
#Customers #Expand